To evaluate whether clopidogrel is superior to aspirin in patients of prior bypass surgery
CAPRIE Substudy
26 Aug, 10
CAPRIE Substudy
Aim
Results
- As compared to aspirin, clopidogrel reduced the risk of vascular death by 43%.
- The risk of vascular death, MI, stroke or rehospitalisation for ischemia or bleeding was reduced by 31%
- Rehospitalisation for any bleeding event was reduced by 28.5%
Conclusion
Clopidogrel is superior to aspirin in patients of prior bypass surgery.
Circulation 2001;103: 363-368